SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-10-046822
Filing Date
2010-09-15
Accepted
2010-09-15 17:04:41
Documents
1
Period of Report
2010-09-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd286231.html 3  
1 FORM 3 rrd286231.xml 3 6642
  Complete submission text file 0001181431-10-046822.txt   9311
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Reporting) CIK: 0000014272 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-33489 | Film No.: 101074346
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1201 EASTLAKE AVENUE E SEATTLE WA 98102
Business Address 1201 EASTLAKE AVENUE E SEATTLE WA 98102 206-442-6600
ZYMOGENETICS INC (Issuer) CIK: 0001129425 (see all company filings)

IRS No.: 911144498 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 212-546-4000
Zeus Acquisition Corp (Reporting) CIK: 0001501223 (see all company filings)

State of Incorp.: WA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-33489 | Film No.: 101074345